Chengguo Xing
Affiliations: | Medicinal Chemistry | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Pharmaceutical Chemistry, Organic ChemistryGoogle:
"Chengguo Xing"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Jignesh M. Doshi | grad student | 2008 | UMN |
| David L. Lampi Hermanson | grad student | 2012 | UMN |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jiang Y, Song L, Lin Y, et al. (2023) ROS-mediated SRMS activation confers platinum resistance in ovarian cancer. Oncogene |
| Sun Y, Huang J, Chen Y, et al. (2020) Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease. Bioorganic Chemistry. 103: 104172 |
| Bian T, Tagmounti A, Vulpe C, et al. (2020) CXL146, a novel 4H-chromene derivative, targets GRP78 to selectively eliminate multidrug resistant cancer cells. Molecular Pharmacology |
| Botello JF, Corral P, Bian T, et al. (2019) Kava and its Kavalactones Inhibit Norepinephrine-induced Intracellular Calcium Influx in Lung Cancer Cells. Planta Medica |
| Cong H, Xu L, Wu Y, et al. (2019) Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives. Journal of Medicinal Chemistry |
| Xing C, Wang Y, Fujioka N, et al. (2019) Abstract 3333: Potential of kava in reducing lung cancer risk, tobacco use, and associated disparities Cancer Research. 79: 3333-3333 |
| Cong H, Zhao X, Castle BT, et al. (2018) An indole-chalcone inhibits multidrug-resistant cancer cell growth by targeting microtubules. Molecular Pharmaceutics |
| Bian T, Chandagirikoppal Vijendra K, Wang Y, et al. (2018) Exploring the structure activity relationship and mechanism of a chromene scaffold (CXL series) for its selective anti-proliferative activity towards multidrug resistant cancer cells. Journal of Medicinal Chemistry |
| Puppala M, Narayanapillai SC, Leitzman P, et al. (2017) Pilot in vivo structure-activity relationship of dihydromethys-ticin in blocking 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced O6-methylguanine and lung tumor in A/J mice. Journal of Medicinal Chemistry |
| Zhuang C, Zhang W, Sheng C, et al. (2017) Chalcone: A Privileged Structure in Medicinal Chemistry. Chemical Reviews |